Clinical Trials
5 trialsNCT05473325 2022-08-15
BRANCH-P
Willows Health
Unknown
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT03785938 2018-12-24
MaCROS
University of Leeds
Phase NA Unknown
NCT00533078 2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2 Completed